File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Role of Metabolism in Adoptive T Cell Therapy: Strategies and Challenges

TitleRole of Metabolism in Adoptive T Cell Therapy: Strategies and Challenges
Authors
Keywordsadoptive T cell therapy
cancer
immunology
metabolism
Issue Date1-Dec-2022
PublisherMary Ann Liebert
Citation
Antioxidants and Redox Signaling, 2022, v. 37, n. 16-18, p. 1303-1324 How to Cite?
Abstract

Significance: Immune cell therapy involves the administration of immune cells into patients, and it has emerged as one of the most common type of immunotherapy for cancer treatment. Knowledge on the biology and metabolism of the adoptively transferred immune cells and the metabolic requirements of different cell types in the tumor is fundamental for the development of immune cell therapy with higher efficacy.

Recent Advances: Adoptive T cell therapy has been shown to be effective in limited types of cancer. Different types and generations of adoptive T cell therapies have evolved in the recent decade. This review covers the basic principles and development of these therapies in cancer treatment.

Critical Issues: Our review provides an overview on the basic concepts on T cell metabolism and highlights the metabolic requirements of T and adoptively transferred T cells.

Future Directions: Integrating the knowledge just cited will facilitate the development of strategies to maximize the expansion of adoptively transferred T cells ex vivo and in vivo and to promote their durability and antitumor effects.


Persistent Identifierhttp://hdl.handle.net/10722/331879
ISSN
2023 Impact Factor: 5.9
2023 SCImago Journal Rankings: 1.708
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorTan, Ge Hui-
dc.contributor.authorWong, Carmen Chak-Lui-
dc.date.accessioned2023-09-28T04:59:19Z-
dc.date.available2023-09-28T04:59:19Z-
dc.date.issued2022-12-01-
dc.identifier.citationAntioxidants and Redox Signaling, 2022, v. 37, n. 16-18, p. 1303-1324-
dc.identifier.issn1523-0864-
dc.identifier.urihttp://hdl.handle.net/10722/331879-
dc.description.abstract<p><strong><em>Significance:</em></strong> Immune cell therapy involves the administration of immune cells into patients, and it has emerged as one of the most common type of immunotherapy for cancer treatment. Knowledge on the biology and metabolism of the adoptively transferred immune cells and the metabolic requirements of different cell types in the tumor is fundamental for the development of immune cell therapy with higher efficacy.</p><p><strong><em>Recent Advances:</em></strong> Adoptive T cell therapy has been shown to be effective in limited types of cancer. Different types and generations of adoptive T cell therapies have evolved in the recent decade. This review covers the basic principles and development of these therapies in cancer treatment.</p><p><strong><em>Critical Issues:</em></strong> Our review provides an overview on the basic concepts on T cell metabolism and highlights the metabolic requirements of T and adoptively transferred T cells.</p><p><strong><em>Future Directions:</em></strong> Integrating the knowledge just cited will facilitate the development of strategies to maximize the expansion of adoptively transferred T cells <em>ex vivo</em> and <em>in vivo</em> and to promote their durability and antitumor effects.</p>-
dc.languageeng-
dc.publisherMary Ann Liebert-
dc.relation.ispartofAntioxidants and Redox Signaling-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectadoptive T cell therapy-
dc.subjectcancer-
dc.subjectimmunology-
dc.subjectmetabolism-
dc.titleRole of Metabolism in Adoptive T Cell Therapy: Strategies and Challenges-
dc.typeArticle-
dc.identifier.doi10.1089/ars.2022.0037-
dc.identifier.scopuseid_2-s2.0-85143645642-
dc.identifier.volume37-
dc.identifier.issue16-18-
dc.identifier.spage1303-
dc.identifier.epage1324-
dc.identifier.eissn1557-7716-
dc.identifier.isiWOS:000820055700001-
dc.identifier.issnl1523-0864-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats